Retrospective cohort study evaluates Oakland Score's impact on adverse outcomes in LGIB, indicating its clinical utility.
Key Points
This study aims to assess the prognostic factors for patients with lower gastrointestinal bleeding and evaluate the Oakland Score's correlation with adverse outcomes.
Conducted a retrospective cohort analysis of 890 patients presenting with LGIB from 2015-2024.
Evaluated the Oakland Score and its relationship with clinical outcomes including mortality, ICU admission, and blood transfusions.
Utilized receiver operating characteristic (ROC) analysis to assess the score's discriminative performance.
The Oakland Score significantly correlated with mortality and ICU admissions (all p < 0.05).
ROC analysis showed the score had an AUC of 0.754 for ICU admission and 0.706 for mortality.
The Oakland Score predicted one-month rebleeding independently (OR 1.082; 95% CI 1.032–1.133; p = 0.001).